B T Teh Selected Research

Hyperparathyroidism 2

1/2017	Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome.
6/2005	HRPT2, a tumor suppressor gene for hyperparathyroidism-jaw tumor syndrome.
12/2004	Renal neoplasia in the hyperparathyroidism-jaw tumor syndrome.
9/2003	HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

B T Teh Research Topics

Disease

18	Neoplasms (Cancer) 01/2018 - 02/2000
4	Carcinogenesis 01/2019 - 08/2001
4	Hyperparathyroidism 2 01/2017 - 09/2003
4	Parathyroid Neoplasms (Parathyroid Neoplasm) 01/2017 - 12/2002
4	Renal Cell Carcinoma (Grawitz Tumor) 03/2016 - 08/2001
4	Hyperparathyroidism 06/2005 - 08/2000
2	Carcinoma (Carcinomatosis) 03/2016 - 09/2003
2	Pheochromocytoma 08/2005 - 02/2000
2	Paraganglioma (Paragangliomas) 08/2005 - 02/2000
1	Ameloblastoma 01/2019
1	Squamous Cell Carcinoma of Head and Neck 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Cholangiocarcinoma 02/2016
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2016
1	Nasopharyngeal Carcinoma 12/2011
1	Pituitary Neoplasms (Pituitary Adenoma) 09/2009
1	Carcinoid Tumor (Carcinoid) 04/2006
1	Tracheal Stenosis 11/2003
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 09/2003
1	Adenoma (Adenomas) 09/2003
1	Multiple Endocrine Neoplasia Type 1 05/2002
1	Primary Hyperparathyroidism 07/2000

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2017 - 12/2002
2	Biological ProductsIBA 05/2017 - 12/2004
2	DNA (Deoxyribonucleic Acid)IBA 03/2016 - 12/2011
2	Histones (Histone)IBA 03/2016 - 09/2001
2	Complementary DNA (cDNA)IBA 08/2005 - 08/2001
2	LithiumIBA 09/2003 - 05/2002
1	CarcinogensIBA 01/2019
1	MutagensIBA 01/2019
1	Co-Repressor ProteinsIBA 01/2019
1	tofacitinibIBA 01/2018
1	Amino Acids FDA Link 01/2017
1	Galectin 3 (LGALS3)IBA 01/2017
1	Messenger RNA (mRNA)IBA 03/2016
1	RNA (Ribonucleic Acid)IBA 03/2016
1	Lysine (L-Lysine)FDA Link 03/2016
1	ChromatinIBA 03/2016
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 02/2016
1	Pharmaceutical PreparationsIBA 02/2016
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 06/2013
1	Untranslated RNA (Noncoding RNA)IBA 06/2013
1	PlatinumIBA 12/2011
1	Cisplatin (Platino)FDA LinkGeneric 12/2011
1	Eukaryotic Initiation Factor-3IBA 12/2011
1	aryl hydrocarbon receptor-interacting proteinIBA 09/2009
1	Azacitidine (5 Azacytidine)FDA Link 01/2008
1	Formaldehyde (Formol)FDA Link 09/2007
1	ParaffinIBA 09/2007
1	Eosine Yellowish-(YS) (Eosin)IBA 08/2005
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 08/2005
1	Keratins (Keratin)IBA 08/2005
1	Histone Deacetylase InhibitorsIBA 04/2004
1	Poly CIBA 12/2002
1	EnzymesIBA 09/2001
1	Nonsense Codon (Nonsense Mutation)IBA 08/2000
1	CatecholaminesIBA 02/2000

Therapy/Procedure

3	Therapeutics 01/2018 - 02/2007
3	Parathyroidectomy 01/2006 - 07/2000
1	Nephrectomy 03/2016
1	Drug Therapy (Chemotherapy) 06/2013
1	Aftercare (After-Treatment) 01/2008
1	Thymectomy 04/2006
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 11/2003